The study, with the participation of Joan XXIII University Hospital and CIBER, analyzes 103 patients and highlights the relationship between hypertension and unfavorable disease progression
Obstructive sleep apnea represents Mineralys’ third precision, targeted indication for lorundrostat, further expanding its market potential in aldosterone-driven diseases
A study coordinated by Dr Francesc Jiménez-Altayó, researcher at the Institut de Neurociències of the UAB (INc-UAB) and at CIBERCV, shows that temporary lack of blood flow to the brain can lead to ...
Researchers at the UAB have carried out two revealing studies on TRPV2, a key ion channel in several cellular functions, which points to it as a possible new therapeutic target in the treatment of hyp...
Mineralys Therapeutics today presented data from the Target-HTN Phase 2 trial that further defines an endotype-specific targeted approach for treating uncontrolled or resistant hypertension with lorun...
Una investigación liderada por la Universidad de Granada y el Instituto de Investigación Biosanitaria ibs.Granada asegura que esta relación es independiente de otros factores como la edad y el cons...